Accessibility Menu
Diagnos logo

Diagnos

(OTC) DGNOF

Current Price$0.14
Market Cap$16.80M
Since IPO (2012)-89%
5 Year-69%
1 Year+3%
1 Month-1%

Diagnos Financials at a Glance

Market Cap

$16.80M

Revenue (TTM)

CA$65.50K

Net Income (TTM)

-CA$4.56M

EPS (TTM)

-$0.03

P/E Ratio

-4.67

Dividend

$0.00

Beta (Volatility)

0.26 (Low)

Price

$0.14

Volume

15,000

Open

$0.14

Previous Close

$0.14

Daily Range

$0.14 - $0.14

52-Week Range

$0.13 - $0.29

Estimated Earnings Date

Aug 24, 2026

DGNOF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Diagnos

Industry

Health Care Technology

CEO

André M. Larente

Headquarters

Brossard, QC J4Z 1A7, CA

DGNOF Financials

Key Financial Metrics (TTM)

Gross Margin

-21%

Operating Margin

-64%

Net Income Margin

-69%

Return on Equity

-1008%

Return on Capital

-2%

Return on Assets

-1%

Earnings Yield

-21.41%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$16.80M

Shares Outstanding

120.41M

Volume

15.00K

Avg. Volume

85.50K

Financials (TTM)

Gross Profit

-CA$119.76K

Operating Income

-CA$4.27M

EBITDA

-CA$4.14M

Operating Cash Flow

-CA$4.01M

Capital Expenditure

-CA$11.09K

Free Cash Flow

-CA$4.02M

Cash & ST Invst.

CA$1.93M

Total Debt

CA$1.41M

Diagnos Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2026YOY CHG

Revenue

CA$15.75K

-14.4%

Gross Profit

-CA$352.82K

-21.5%

Gross Margin

-22.40%

N/A

Market Cap

$16.80M

N/A

Market Cap/Employee

$763.53K

N/A

Employees

22

N/A

Net Income

-CA$1.19M

+11.2%

EBITDA

-CA$1.12M

+3.2%

Quarterly Fundamentals

Name
Q4 2026YOY CHG

Total Cash

CA$1.93M

-40.3%

Total Debt

CA$1.41M

-54.3%

Accounts Receivable

CA$212.93K

+39.7%

Inventory

CA$0.00

N/A

Long Term Debt

CA$226.29K

-20.9%

Short Term Debt

CA$1.18M

-57.7%

Return on Assets

-1.21%

N/A

Return on Invested Capital

-2.44%

N/A

Free Cash Flow

-CA$1.32M

-6.0%

Operating Cash Flow

-CA$1.32M

-6.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
IPDQFImpediMed Limited
$0.01+0.00%
MRAIMarpai, Inc.
$0.57+10.14%
CLYYFCelyad Oncology S.A.
$0.25+0.00%
POSCPositron Corporation
$1.79-1.16%

Trending Stocks

Symbol / CompanyPricePrice Chg
AALAmerican Airlines Group
$14.98+0.02%
NOKNokia
$14.80+0.05%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$13.59+0.04%
TQQQProShares Trust - ProShares UltraPro Qqq
$77.52+0.02%

Questions About DGNOF

What is the current price of Diagnos?

Diagnos is trading at $0.14 per share.

What is the 52-week range for Diagnos?

Over the past 52 weeks, Diagnos has traded between $0.13 and $0.29.

How much debt does Diagnos have?

As of the most recent reporting period, Diagnos reported total debt of CA$1.00M.

How much cash does Diagnos have on hand?

Diagnos reported CA$222.14K in cash and cash equivalents in its most recent financial results.

What is Diagnos’s dividend yield?

Diagnos does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.